scholarly journals Molecular Basis of DNA Repair Defects in FUS-Associated ALS: Implications of a New Paradigm and Its Potential as Therapeutic Target

Author(s):  
Haibo Wang ◽  
Muralidhar L. Hegde

2021 ◽  
Vol 16 (4) ◽  
pp. S813
Author(s):  
A. Suraweera ◽  
P. Duijf ◽  
M. Tang ◽  
C. Jekimovs ◽  
K. Schrobback ◽  
...  


2021 ◽  
Vol 23 (8) ◽  
Author(s):  
Osnat Elyashiv ◽  
Yien Ning Sophia Wong ◽  
Jonathan A. Ledermann

Abstract Purpose of Review Advanced epithelial ovarian cancer remains the most lethal gynaecological cancer. Most patients with advanced disease will relapse within 3 years after primary treatment with surgery and chemotherapy. Recurrences become increasing difficult to treat due to the emergence of drug resistance and 5-year survival has changed little over the last decade. Maintenance treatment, here defined as treatment given beyond primary chemotherapy, can both consolidate the response and prolong the control of disease which is an approach to improve survival. Recent Findings Here we review maintenance strategies such as targeting angiogenesis, interference of DNA repair through inhibition of PARP, combinations of targeting agents, and immunotherapy and hormonal therapy. Summary Much has been learnt from the success and challenges of these treatments that have in the last few years which led to significant reduction in disease recurrence, changed the guidelines for treatment, and established a new paradigm for the treatment of ovarian cancer.



2006 ◽  
Vol 66 (16) ◽  
pp. 8219-8226 ◽  
Author(s):  
Andrew J. Deans ◽  
Kum Kum Khanna ◽  
Carolyn J. McNees ◽  
Ciro Mercurio ◽  
Jörg Heierhorst ◽  
...  


2019 ◽  
Vol 202 (2) ◽  
Author(s):  
Miyako Shiraishi ◽  
Shigenori Iwai

ABSTRACT Endonuclease Q (EndoQ), a DNA repair endonuclease, was originally identified in the hyperthermophilic euryarchaeon Pyrococcus furiosus in 2015. EndoQ initiates DNA repair by generating a nick on DNA strands containing deaminated bases and an abasic site. Although EndoQ is thought to be important for maintaining genome integrity in certain bacteria and archaea, the underlying mechanism catalyzed by EndoQ remains unclear. Here, we provide insights into the molecular basis of substrate recognition by EndoQ from P. furiosus (PfuEndoQ) using biochemical approaches. Our results of the substrate specificity range and the kinetic properties of PfuEndoQ demonstrate that PfuEndoQ prefers the imide structure in nucleobases along with the discovery of its cleavage activity toward 5,6-dihydrouracil, 5-hydroxyuracil, 5-hydroxycytosine, and uridine in DNA. The combined results for EndoQ substrate binding and cleavage activity analyses indicated that PfuEndoQ flips the target base from the DNA duplex, and the cleavage activity is highly dependent on spontaneous base flipping of the target base. Furthermore, we find that PfuEndoQ has a relatively relaxed substrate specificity; therefore, the role of EndoQ in restriction modification systems was explored. The activity of the EndoQ homolog from Bacillus subtilis was found not to be inhibited by the uracil glycosylase inhibitor from B. subtilis bacteriophage PBS1, whose genome is completely replaced by uracil instead of thymine. Our findings suggest that EndoQ not only has additional functions in DNA repair but also could act as an antiviral enzyme in organisms with EndoQ. IMPORTANCE Endonuclease Q (EndoQ) is a lesion-specific DNA repair enzyme present in certain bacteria and archaea. To date, it remains unclear how EndoQ recognizes damaged bases. Understanding the mechanism of substrate recognition by EndoQ is important to grasp genome maintenance systems in organisms with EndoQ. Here, we find that EndoQ from the euryarchaeon Pyrococcus furiosus recognizes the imide structure in nucleobases by base flipping, and the cleavage activity is enhanced by the base pair instability of the target base, along with the discovery of its cleavage activity toward 5,6-dihydrouracil, 5-hydroxyuracil, 5-hydroxycytosine, and uridine in DNA. Furthermore, a potential role of EndoQ in Bacillus subtilis as an antiviral enzyme by digesting viral genome is demonstrated.



2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Nigel C. Brissett ◽  
Katerina Zabrady ◽  
Przemysław Płociński ◽  
Julie Bianchi ◽  
Małgorzata Korycka-Machała ◽  
...  


2012 ◽  
Vol 12 (12) ◽  
pp. 801-817 ◽  
Author(s):  
Nicola J. Curtin


2018 ◽  
Author(s):  
Daniele Caracciolo ◽  
Martina Montesano ◽  
Emanuela Altomare ◽  
Grazia Consolo ◽  
Nicola Amodio ◽  
...  


2015 ◽  
Vol 56 (3) ◽  
pp. 319-337 ◽  
Author(s):  
David E. Hanson ◽  
John L. Barber


Author(s):  
G. Weeda ◽  
J. de Boer ◽  
I. Donker ◽  
J. de Wit ◽  
S. B. Winkler ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document